Melbourne Mobile Stroke Unit and Reperfusion Therapy Greater Clinical Impact of Thrombectomy Than Thrombolysis
Henry Zhao, Skye Coote, Damien Easton, Francesca Langenberg, Michael Stephenson, Karen Smith, Stephen Bernard, Dominique A Cadilhac, Joosup Kim, Christopher F Bladin, Leonid Churilov, Douglas E Crompton, Helen M Dewey, Lauren M Sanders, Tissa Wijeratne, Geoffrey Cloud, Duncan M Brooks, Hamed Asadi, Vincent Thijs, Ronil V Chandra Show all
Stroke | LIPPINCOTT WILLIAMS & WILKINS | Published : 2020
Background and Purpose- Mobile stroke units (MSUs) are increasingly used worldwide to provide prehospital triage and treatment. The benefits of MSUs in giving earlier thrombolysis have been well established, but the impacts of MSUs on endovascular thrombectomy (EVT) and effect on disability avoidance are largely unknown. We aimed to determine the clinical impact and disability reduction for reperfusion therapies in the first operational year of the Melbourne MSU. Methods- Treatment time metrics for MSU patients receiving reperfusion therapy were compared with control patients presenting to metropolitan Melbourne stroke units via standard ambulance within MSU operating hours. The primary outc..View full abstract
The Melbourne Mobile Stroke Unit and associated projects received funding from the Australian Commonwealth Government, Victorian State Government, Royal Melbourne Hospital Neurosciences Foundation, Stroke Foundation, The Florey Institute of Neurosciences and Mental Health, the University of Melbourne, Boehringer Ingelheim, and private donation.